ClearPoint Neuro CLPT Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from ClearPoint Neuro’s reported figures.
Based on the most recent quarter.
The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about ClearPoint Neuro's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ClearPoint Neuro's debt-to-equity?
- ClearPoint Neuro (CLPT) reported debt-to-equity of 3.4× in Q1 2026.
- How has ClearPoint Neuro's debt-to-equity changed year-over-year?
- ClearPoint Neuro's debt-to-equity increased by 1862.2% year-over-year, from 0.2× to 3.4×.
- What is the long-term trend for ClearPoint Neuro's debt-to-equity?
- Over 5 years (2020 to 2025), ClearPoint Neuro's debt-to-equity has grown at a -27.3% compound annual growth rate (CAGR), from 10.2× to 2.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.